Regeneron Pharmaceuticals REGN Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's preferred stock, shares authorized?
- Regeneron Pharmaceuticals (REGN) reported preferred stock, shares authorized of 30M in Q1 2026.
- How has Regeneron Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- Regeneron Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from 30M to 30M.
- What is the long-term trend for Regeneron Pharmaceuticals's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from 30M to 30M.